- Report
- August 2023
- 1350 Pages
Global
From €8243EUR$8,900USD£6,914GBP
- Report
- August 2023
- 51 Pages
Argentina
From €556EUR$600USD£466GBP
- Report
- August 2023
- 51 Pages
South Korea
From €556EUR$600USD£466GBP
- Report
- August 2023
- 51 Pages
South Africa
From €556EUR$600USD£466GBP
- Report
- August 2023
- 51 Pages
Australia
From €556EUR$600USD£466GBP
- Report
- August 2023
- 51 Pages
Saudi Arabia
From €556EUR$600USD£466GBP
- Report
- August 2023
- 51 Pages
Colombia
From €556EUR$600USD£466GBP
- Report
- August 2023
- 51 Pages
United States
From €556EUR$600USD£466GBP
- Report
- August 2023
- 51 Pages
United Kingdom
From €556EUR$600USD£466GBP
- Report
- August 2023
- 51 Pages
Netherlands
From €556EUR$600USD£466GBP
- Report
- August 2023
- 51 Pages
Germany
From €556EUR$600USD£466GBP
From €556EUR$600USD£466GBP
- Report
- August 2023
- 51 Pages
Japan
From €556EUR$600USD£466GBP
- Report
- August 2023
- 51 Pages
Israel
From €556EUR$600USD£466GBP
- Report
- August 2023
- 51 Pages
Mexico
From €556EUR$600USD£466GBP
- Report
- August 2023
- 51 Pages
Canada
From €556EUR$600USD£466GBP
- Report
- August 2023
- 51 Pages
Italy
From €556EUR$600USD£466GBP
- Report
- August 2023
- 51 Pages
China
From €556EUR$600USD£466GBP
- Report
- August 2023
- 51 Pages
France
From €556EUR$600USD£466GBP
- Report
- August 2023
- 51 Pages
Brazil
From €556EUR$600USD£466GBP
T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more